At Dr. Reddy’s, we make quality pharmaceuticals affordable – delivering value to the pharmacy and quality, low-cost alternatives to all who need them. Amid changing market conditions and industry cycles, we’re reining in healthcare costs while improving access to medications across the United States and Canada. Since the launch of our first finished dosage-form products in North America more than a decade ago, we’ve made great strides bringing a variety of new generics, OTCs, and other pharmaceuticals to market.
Dr. Reddy’s at a Glance
- Prescription products: 50 products are marketed under
Dr. Reddy’s label in 250+ dosing presentations
- OTC products: 11 products are marketed in 200+ store-brand packaging presentations (private label)
- Robust pipeline: 76 ANDAs are pending, of which 40 are Para IV certifications and 11 FTFs
- Dosage forms: Oral solids, injectables, topicals, and other forms are available
- 24 Rx products ranked top 3 in market share
With our continuing investments in product development, aggressive acquisitions, and advances in research, processes, and technologies, we’re meeting the demands of a changing market. Dr. Reddy’s is a vertically integrated global pharmaceutical company from India and is among the leaders in the supply of generic API’s worldwide. Dr. Reddy’s has 13 facilities, including API and finished dosage manufacturing. There are 8 API facilities globally which are FDA-inspected and 4 FDA-approved finished dosage facilities servicing the US. We have the capabilities to help overcome market entry barriers, such as formulation, manufacturing, API, delivery method, and intellectual property. We are also uniquely positioned to support Rx-to-OTC switches. Discover for yourself how our diverse line of generics, OTCs, and other affordable medicines can make the difference. Make Dr. Reddy’s your low-cost provider of quality pharmaceutical products.